Drug name - Aloxi

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9066980 HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron Jan, 2024

(1 year, 5 months from now)

US8729094 HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron Jan, 2024

(1 year, 5 months from now)

US9457020 HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron Jan, 2024

(1 year, 5 months from now)

US8518981 HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron Jan, 2024

(1 year, 5 months from now)

US9439854 HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron Jan, 2024

(1 year, 5 months from now)

US7947725 HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron Jan, 2024

(1 year, 5 months from now)

US8598218 HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron Jan, 2024

(1 year, 5 months from now)

US9457021 HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron Jan, 2024

(1 year, 5 months from now)

US9125905 HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron Jan, 2024

(1 year, 5 months from now)

US7960424 HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron Jan, 2024

(1 year, 5 months from now)

US9173942 HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron Jan, 2024

(1 year, 5 months from now)

US7947724 HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron Jan, 2024

(1 year, 5 months from now)

US8598219 HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron Jan, 2024

(1 year, 5 months from now)

US7947724

(Pediatric)

HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron Jul, 2024

(1 year, 11 months from now)

US7947725

(Pediatric)

HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron Jul, 2024

(1 year, 11 months from now)

US7960424

(Pediatric)

HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron Jul, 2024

(1 year, 11 months from now)

US8518981

(Pediatric)

HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron Jul, 2024

(1 year, 11 months from now)

US8598218

(Pediatric)

HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron Jul, 2024

(1 year, 11 months from now)

US9173942

(Pediatric)

HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron Jul, 2024

(1 year, 11 months from now)

US9439854

(Pediatric)

HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron Jul, 2024

(1 year, 11 months from now)

US9457020

(Pediatric)

HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron Jul, 2024

(1 year, 11 months from now)

US8729094

(Pediatric)

HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron Jul, 2024

(1 year, 11 months from now)

US8598219

(Pediatric)

HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron Jul, 2024

(1 year, 11 months from now)

US9125905

(Pediatric)

HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron Jul, 2024

(1 year, 11 months from now)

US9457021

(Pediatric)

HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron Jul, 2024

(1 year, 11 months from now)

US9066980

(Pediatric)

HELSINN HLTHCARE Liquid pharmaceutical formulations of palonosetron Jul, 2024

(1 year, 11 months from now)

Drugs and Companies using PALONOSETRON HYDROCHLORIDE ingredient

Treatment: Prevention of chemotherapy-induced nausea and vomiting

Dosage: INJECTABLE;INTRAVENOUS

More Information on Dosage
Strength Dosage Availability
EQ 0.075MG BASE/1.5ML (EQ 0.05MG BASE/ML) INJECTABLE;INTRAVENOUS Discontinued
EQ 0.25MG BASE/5ML (EQ 0.05MG BASE/ML) INJECTABLE;INTRAVENOUS Discontinued